All Articles

Shared genetic architecture between metabolic dysfunction-associated steatotic liver disease and cardiometabolic traits comorbidities: a genome-wide pleiotropic and multi-omics study

Impact of obstructive sleep apnea on postoperative outcomes after SADI-S: a retrospective MBSAQIP database analysis with literature review on behalf of TROGSS - The Robotic Global Surgical Society

Prognostic performance of the neutrophil-lymphocyte ratio for early complications following sleeve gastrectomy

MASLD or MAFLD: fatty liver by any name will pose the same challenge

Metabolism, sex, and what lies beyond the scalpel in MASLD

Regulatory T cell-based therapies for type 1 diabetes: a narrative review

Monitoring and treatment of alcohol use disorder: an integrated multidisciplinary model

Dual etiology vs. MetALD: how MAFLD and MASLD address liver diseases coexistence

Challenges in the management of MetALD after liver transplantation

Robotic metabolic and bariatric surgery in community vs. academic centers in USA: a bibliometric analysis on behalf of TROGSS - The Robotic Global Surgical Society

Duodenal mucosa resurfacing: the endoscopic silver bullet against metabolic disorders?

Mini liver organoid models emulating metabolic dysfunction-associated steatotic disease development: gradually emerging beneath the iceberg

Physical exercise for obesity and T2DM mitigation in polycystic ovary syndrome: the role of adipose tissue

From NAFLD to MASLD: transforming steatotic liver disease diagnosis and management

An initiative to promote the integration of artificial intelligence in transforming the diagnosis and management of Wilson disease in the 21st century

Machine learning models and AI in predicting diagnosis and prognosis in alcohol-related and metabolic dysfunction-associated steatotic liver disease

Predictors of testosterone recovery in male patients with nonfunctioning pituitary adenoma treated with transnasal transsphenoidal extrapseudocapsular microsurgery

Research progress and future prospects of small-molecule glucagon-like peptide-1 receptor agonists (GLP-1RAs)